Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Poland: Cause of death, by non-communicable diseases, ages 5-14, male

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
28.1%
in 2021
Poland
60.3%
in 2021
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
24th
Poland rank
25th

Cause of death, by non-communicable diseases, ages 5-14, male over time

  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
  • Poland
0204060200020102021

How they compare

Poland currently reports 60.3% against 28.1% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 32.2%.

That makes Poland's figure about 2.1 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 6 years both countries report, Poland has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 24th and Poland ranks 25th of 47 groups.

Poland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Poland Difference Ahead
2000s 25.0% 45.9% 20.9% Poland
2010s 26.2% 55.4% 29.2% Poland
2020s 27.9% 60.1% 32.2% Poland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Poland?
Poland, at 60.3% against 28.1% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Poland?
32.2%, with Poland ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Poland?
6 years are reported by both, from 2000 to 2021.
How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Poland rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 24th and Poland ranks 25th of 47 groups.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Poland: Cause of death, by non-communicable diseases, ages 5-14, male. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-male-percent-of-total-male-deaths/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/poland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-male-percent-of-total-male-deaths/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/poland/">Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Poland: Cause of death, by non-communicable diseases, ages 5-14, male</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14)
Unit
% of total male deaths ages 5-14
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.